|
1) Carvalho MV, Malnf MA, Catani R, et al. Cytokines and pediatric open heart surgery with cardiopulmonary bypass. Cardio Toung. 2001; 11: 36-43
|
|
|
|
|
2) Parker DJ, Cantrell G, Stroud R, et al. Changes in serum complement and the immunoglobulins after cardiopulmonary bypass. Br J Surg. 1972; 59: 910-1
|
|
|
|
|
|
3) Silva J Jr, Hoeksema H, Fekety FRJr. Transient defects in phagocytic functions during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1974; 67: 175-83
|
|
|
|
|
4) Coselli JS, Koksoy C, LeMaire SA. Management of thoracic aortic graft infection. Ann Thorac Surg. 1999; 67: 1990-3
|
|
|
|
|
5) Domkowski PW, Smith ML, Gonyon DL, et al. Evaluation of vacuum-assisted closure in the treatment of poststernotomy mediastinitis. J Thorac Cardiovasc Surg. 2003; 126: 386-90
|
|
|
|
|
|
6) Akowuah E, Narayan P, Angelini G, et al. Management of prosthetic graft infection after surgery of the thoracic aorta: Removal of the prosthetic garaft is not necessary. J Thorac Cardiovasc Surg. 2007; 134: 1051-2
|
|
|
|
|
|
7) San Juan R, Chaves F, Gude MJL, et al. Staphylococcus aureus poststernotomy mediastinitis: Description of two distinct acquisition path way with different potential preventive approaches. J Thorac Cardiovasc Surg. 2007; 134: 670-6
|
|
|
|
|
|
8) Abboud CS, Wey SB, Baltar VT. Risk factors for mediastinitis after cardiac surgery. Ann Thorac Surg. 2004; 77: 676-83
|
|
|
|
|
|
9) Maki DG, Bhon MJ, Srolz SM, et al. Comparative study of cefazolin, cefamandole, and vancomycin for surgical prophylaxis in cardiac and vascular operations. A double-blind randomized trial. J Thorac Cardiovasc Surg. 1992; 104: 1423-34
|
|
|
|
|
|
10) Harbarth S, Samore MH, Lichtenberg D, et al. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circularion. 2000; 101: 2916-21
|
|
|
|
|
|
11) Fowler VG, O'Brien SM, Muhlbaier LH, et al. Clinical predictors of major infections after cardiac surgery. Circulation. 2005; 112: I358-65
|
|
|
|
|
|
12) Payne WS, Larson RH. Acute mediastinitis. Surg Clin North Am. 1969; 49: 999-1009
|
|
|
|
|
|
13) Gummert JF, Barten MJ, Hans C, et al. Mediastinitis and cardiac surgery-an update risk factor analysis in 10, 373 consecutive patients. J Thorac Cardiovasc Surg. 2002; 50: 87-91
|
|
|
|
|
|
14) Morykwas MJ, Argenta LC, Shelton B, et al. Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation. Ann Plast Surg. 1997; 38: 553-62
|
|
|
|
|
|
15) Saiki Y, Hata M, Akasaka J, et al. Vacuum treatment of mediastinitis after total aortic arch replacement. Jpn J Thorac Cardiovasc Surg. 2005; 53: 638-40
|
|
|
|
|
16) Gustafsson R, Sjogren J, Malmsjo M, et al. Vacuum-assisted closure of the sternotomy wound: respiratory mechanics and ventilation. Plast Reconstr Surg. 2006; 117: 1167-76
|
|
|
|
|
|
17) LeMaire SA, Coselli JS. Options for managing infected ascending aortic grafts. J Thorac Cardiovasc Surg. 2007; 134: 839-43
|
|
|
|
|
|
18) Vogt PR, Brunner-La Rocca HP, Carrel T, et al. Cryopreserved arterial allografts in the treatment of major vascular infection: a comparison with conventional surgical technique. J Thorac Cardiovasc Surg. 1998; 116: 965-72
|
|
|
|
|
|
19) Sato S, Saiki Y, Nitta Y, et al. Redo total aortic arch replacement using an extended homograft for graft infection. Jpn J Thorac Cardiovasc Surg. 2006; 54: 448-50
|
|
|
|
|
|
20) Saito A, Motomura N, Kakimi K, et al. Vascular allografts are resistant to methicillin-resistant Staphylococcus aureus through indoleamine 2, 3-dioxygenase in a murine model. J Thorac Cardiovasc Surg. 2008; 36: 159-67
|
|
|
|
|